Gilman Hill Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.89M	Buy	11,754 +3,386	+40%	+$1.63M	0.81%	51
2026 Q1	$4.11M	Buy	8,368 +365	+5%	+$198K	0.62%	68
2025 Q4	$4.64M	Buy	8,003 +897	+13%	+$507K	0.73%	65
2025 Q3	$3.45M	Buy	7,106 +178	+3%	+$82.9K	0.54%	75
2025 Q2	$2.81M	Buy	6,928 +125	+2%	+$52.3K	0.46%	76
2025 Q1	$3.39M	Buy	6,803 +48	+0.7%	+$26K	0.59%	67
2024 Q4	$3.51M	Buy	6,755 +273	+4%	+$150K	0.61%	65
2024 Q3	$4.01M	Buy	6,482 +46	+0.7%	+$27.2K	0.67%	58
2024 Q2	$3.56M	Buy	6,436 +79	+1%	+$45.3K	0.64%	65
2024 Q1	$3.69M	Buy	6,357 +33	+0.5%	+$18.5K	0.66%	59
2023 Q4	$3.36M	Sell	6,324 -23	-0.4%	-$11.1K	0.62%	58
2023 Q3	$3.21M	Buy	6,347 +148	+2%	+$78.9K	0.63%	57
2023 Q2	$3.23M	Buy	6,199 +169	+3%	+$91.2K	0.6%	60
2023 Q1	$3.48M	Buy	6,030 +395	+7%	+$223K	0.71%	53
2022 Q4	$3.1M	Buy	5,635 +958	+20%	+$508K	0.64%	54
2022 Q3	$2.37M	Sell	4,677 -67	-1%	-$37.5K	0.55%	58
2022 Q2	$2.58M	Buy	4,744 +559	+13%	+$308K	0.55%	53
2022 Q1	$2.47M	Buy	4,185 +478	+13%	+$275K	0.56%	60
2021 Q4	$2.47M	Sell	3,707 -75	-2%	-$46.8K	0.55%	57
2021 Q3	$2.16M	Buy	3,782 +35	+0.9%	+$19.2K	0.55%	62
2021 Q2	$1.89M	Buy	3,747 +826	+28%	+$390K	0.48%	65
2021 Q1	$1.33M	Buy	2,921 +533	+22%	+$254K	0.37%	76
2020 Q4	$1.11M	Buy	2,388 +148	+7%	+$69.4K	0.36%	80
2020 Q3	$989K	Sell	2,240 -190	-8%	-$78.5K	0.38%	72
2020 Q2	$880K	Sell	2,430 -8	-0.3%	-$2.68K	0.35%	77
2020 Q1	$691K	Buy	+2,438	New	+$769K	0.34%	85

Other funds holding TMO